Project Planning Of Biosimilar Development Compounds

The Biosimilars Group Offers New Approach To Project Planning Of Biosimilar Development Compounds

March 23, 2015 / The Biosimilars Group offers as a new and unique service to its clients – a one-day workshop for full biosimilar development project planning. In this workshop senior experts from The Biosimilars Group and representatives from the client’s organization will develop a tailor-made project plan from start of cell-line development up to and including the first clinical study.

“The project planning workshop is an ideal service for companies, who need a basis for the NPV calculation of a biosimilar project or who want to do a feasibility study” says Roland Meisel, PhD, representing Process Development and Manufacturing at The Biosimilars Group. Martin Blüggel, responsible for analytics driven biosimilars development, adds: “Of course, companies can also use this service in order to benchmark own internal project plans. And it delivers results quickly as The Biosimilars Group can staff the workshop with own senior experts representing all major development areas.”

The members of The Biosimilars Group are all renowned service providers with a track record in biosimilars development. They have successfully completed over 80 projects across all functions in the past 5 years and have more than 10 years of experience in biosimilar development. Overall, there are more than 500 highly qualified professionals in the group. The partner companies are operating more than 15 sites on three continents.

The Biosimilars Group will be available for discussions also at the EBG Biosimilars Conference in London, on April 23-24, 2015 and at the Bio International Convention in Philadelphia, on June 15-18, 2015.